Fortis Advisors LLC Purchases 650 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Fortis Advisors LLC lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 12.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 5,950 shares of the exchange traded fund’s stock after purchasing an additional 650 shares during the period. Fortis Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $536,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of XBI. Bank of New York Mellon Corp boosted its stake in shares of SPDR S&P Biotech ETF by 15.4% during the second quarter. Bank of New York Mellon Corp now owns 5,590 shares of the exchange traded fund’s stock valued at $518,000 after purchasing an additional 744 shares during the period. BOKF NA boosted its position in SPDR S&P Biotech ETF by 65.5% in the 2nd quarter. BOKF NA now owns 1,390 shares of the exchange traded fund’s stock valued at $129,000 after buying an additional 550 shares during the period. Envestnet Asset Management Inc. grew its stake in SPDR S&P Biotech ETF by 12.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock worth $17,281,000 after acquiring an additional 20,685 shares in the last quarter. Greenwich Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 10.3% during the second quarter. Greenwich Wealth Management LLC now owns 11,505 shares of the exchange traded fund’s stock worth $1,067,000 after acquiring an additional 1,073 shares during the period. Finally, Bcwm LLC raised its stake in shares of SPDR S&P Biotech ETF by 4.2% during the second quarter. Bcwm LLC now owns 42,915 shares of the exchange traded fund’s stock valued at $3,979,000 after acquiring an additional 1,742 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.3 %

Shares of NYSEARCA:XBI opened at $89.13 on Tuesday. The business’s 50 day moving average is $95.28 and its 200 day moving average is $97.10. The stock has a market cap of $6.79 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.